Literature DB >> 5445935

Australia antigen: distribution during Cohn ethanol fractionation of human plasma.

D D Schroeder, M M Mozen.   

Abstract

When plasma containing a hepatitis-associated antigen (Au/SH) is fractionated, the antigen is localized in fractions III and IV with none in fraction II and only small amounts in fractions I and V. The amount of antigen found in each of these fractions is probably not predictive of clinical infectivity of Cohn ethanol fractions from normnal pooled plasna.

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5445935     DOI： 10.1126/science.168.3938.1462

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  12 in total

1.  An alternative method of large scale plasma fractionation for the isolation of serum albumin.

Authors:  W Schneider; H Lefévre; H Fiedler; L J McCarty
Journal:  Blut       Date:  1975-02

Review 2.  Current transfusion therapy.

Authors:  E Hinkes; R O Steffen
Journal:  Calif Med       Date:  1973-05

3.  Hepatitis after Konyne administration.

Authors:  M M Oken; L Hootkin; R L DeJager
Journal:  Am J Dig Dis       Date:  1972-03

Review 4.  Vitiligo and Melanoma-Associated Vitiligo: Understanding Their Similarities and Differences.

Authors:  Brandon E Cohen; Prashiela Manga; Krysta Lin; Nada Elbuluk
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

Review 5.  The development of virus-free labile blood derivatives--a review.

Authors:  A M Prince; B Horowitz; M S Horowitz; E Zang
Journal:  Eur J Epidemiol       Date:  1987-06       Impact factor: 8.082

6.  Preparation and standardization of an Australia antigen antibody of equine origin.

Authors:  V J Cabasso; R Nieman; D D Schroeder; K A Hok; R E Louie; M M Mozen
Journal:  Appl Microbiol       Date:  1971-06

7.  The Australia (hepatitis-associated) antigen in fibrinogen and other fractions of human plasma.

Authors:  A J Zuckerman; P E Taylor; R G Bird; S M Russell
Journal:  J Clin Pathol       Date:  1971-02       Impact factor: 3.411

Review 8.  Blood protein derivative viral safety: observations and analysis.

Authors:  B Horowitz
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct

Review 9.  Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens.

Authors:  Kang Cai; Todd M Gierman; JoAnn Hotta; Christopher J Stenland; Douglas C Lee; Dominique Y Pifat; Steve R Petteway
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

Review 10.  Current concepts of viral hepatitis and a peek into the future.

Authors:  R S Koff
Journal:  Yale J Biol Med       Date:  1974-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.